Thioredoxin is a major component of thiol-reducing system. Recently, we identified thioredoxin-binding protein-2 (TBP-2) as a negative regulator of thioredoxin. Here, we report the role of TBP-2 in oxidative renal tubular injury and the subsequent carcinogenesis by ferric nitrilotriacetate. TBP-2 was abundantly expressed in the rat kidney. Immunohistochemical analysis revealed that TBP-2 was present in association with nuclei and mitochondrial intermembrane space in the proximal tubular cells and coimmunoprecipitated with cytochrome c. After acute oxidative tubular damage, TBP-2 protein, but not messenger RNA, markedly decreased, demonstrating shortened half-life of this protein. Most cases of the induced renal cell carcinoma showed undetectable levels of TBP-2 protein, which was associated with the methylation of CpG island in the promoter region. Genome sequence analyses identified the poly-A tract in the 3 0 untranslated region as a mutation hot spot in this rather nonselective environment. Collectively, the amounts of TBP-2 protein were inversely associated with proliferation of tubular cells, as evaluated by proliferating cell nuclear antigen. These results suggest that loss of TBP-2 is essential for proliferation of not only neoplastic but also non-neoplastic renal tubular cells, and that TBP-2 is a target gene in oxidative stress-induced renal carcinogenesis by ferric nitrilotriacetate.
Oxidative stress is intimately associated with carcinogenesis. 1 Iron is the most abundantly present transition metal in the human body, and iron overload has been shown to be associated with carcinogenesis 2 presumably via its catalytic effect on the generation of reactive oxygen species (ROS). 3 However, its precise molecular mechanism still remains unclear.
Administration of an iron chelate, ferric nitrilotriacetate (Fe-NTA), provides an intriguing model of iron-mediated oxidative stress-induced carcinogenesis: its intraperitoneal administration induces renal proximal tubular damage (as a consequence of the Fenton reaction) that ultimately leads to up to 90% incidence of renal cell carcinoma (RCC) in rodents. [4] [5] [6] This model is characterized by (1) high incidence of pulmonary metastasis and peritoneal invasion, (2) increase in molecules covalently modified by ROS 7 in the kidney during carcinogenesis, and (3) inhibition of not only acute renal tubular damage but also tumor incidence 8 by pretreatment with a lipophilic antioxidant, a-tocopherol. We previously reported an increase in a variety of oxidatively modified molecules such as 8-oxoguanine, 9 ,10 thymine-tyrosine crosslinks, 11 saturated and unsaturated mutagenic aldehydes including 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA), and HNE-and MDA-modified proteins [12] [13] [14] in the kidney after Fe-NTA administration. Recently, we identified the p15 INK4B and p16 INK4A tumor suppressor genes 15, 16 and the annexin 2 gene 17 as target genes in this model. Thioredoxin (Trx) is a 12-kDa ubiquitous protein that has disulfide-reducing activity within its consensus sequence (-Trp-Cys-Gly-Pro-Cys-) and is involved in a variety of cellular functions including proliferation, antiapoptosis and the activation of transcription factors. [18] [19] [20] Trx constitutes one of the major reducing systems in the cell together with Trx reductase and nicotinamide adenine dinucleotide phosphate, reduced form (NADPH). 21, 22 In 1999, we identified a Trx-binding protein with a yeast two-hybrid assay and named it Trx-binding protein-2 (TBP-2); 23 it was recognized that TBP-2 is identical to vitamin D 3 upregulated protein-1 (VDUP-1) 24 or thioredoxin-interacting protein. 25 In a more recent work, we found that loss of TBP-2 plays an important role in human T-cell leukemia virus type I-induced T-cell transformation. 26 In the present study, we examined the significance of TBP-2 in the Fe-NTA-induced renal cancer model of rats. TBP-2 was abundantly present in the rat renal proximal tubular cells. We report here for the first time that loss or decrease of TBP-2 was a common and critical process for renal tubular proliferation whether it was regenerative or neoplastic, and that TBP-2 was a possible major target gene in this oxidative stress-induced renal carcinogenesis.
Materials and methods

Chemicals
Ferric nitrate enneahydrate, b-nicotinamide adenine dinucletide phosphate (reduced form), cytochrome c, sodium pyruvate and sodium succinate were from Wako (Osaka, Japan); nitrilotriacetic acid disodium salt was from Nacalai Tesque Inc. (Kyoto, Japan). 2-(p-Iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolim chloride and b-nicotinamide adenine dinucleotide (reduced form) were from Sigma (St Louis, MO, USA). All the chemicals used were of analytical quality; deionized water was used throughout. Fe-NTA solution was prepared immediately before use as previously described. 12 
Animal Studies
Fe-NTA-induced RCCs were produced according to a previously described protocol. 27 The acute study of a single injection (15 mg iron/kg; 0, 1, 3, 6, 12, 24 and 48 h) and the subacute study of repeated injections (5-10 mg iron/kg; 3 weeks) were carried out as previously described using 5-week-old specific pathogen-free male Wistar rats (Shizuoka Laboratory Animal Center, Shizuoka, Japan). 9 Fischer-344 and Brown-Norway rat strains were obtained from Charles River Japan Inc. (Yokohama, Japan). The animals were killed and RCCs were collected 12-15 months after the completion of Fe-NTA administration as described. 27 Tumorous and nontumorous portions of renal tissues were excised and stored frozen at À801C. A total of 22 cases of RCCs (one grade-1 tumor, eight grade-2 tumors and 12 grade-3 tumors, of which 13 showed pulmonary metastasis and six showed peritoneal invasion after classification as described 27 ) and one case of adenoma were used.
Antibodies
Yat315 and Yat818 mouse monoclonal antibodies (IgG 1 ) were raised against full-length human recombinant TBP-2. These antibodies recognized rat TBP-2. 26 Anti-mouse Trx rabbit polyclonal antibody that also recognizes rat Trx was used as described. 28 Mouse monoclonal antibody against cytochrome c (clone A-8) was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal antibody against proliferating cell nuclear antigen (PCNA; clone PC-10) was from Dako (Kyoto, Japan). Antiactin monoclonal antibody (clone MAB1501) was purchased from Chemicon International Inc. (Temecula, CA, USA). Horseradish peroxidase-conjugated rabbit antibody against mouse IgG was from Amersham Pharmacia Biotech (Tokyo, Japan), and biotinlabeled rabbit antibody against mouse IgG was from Dako.
Immunoprecipitation and Western Blot Analysis
Tissue lysates were prepared by homogenization in RIPA buffer (20 mM Tris, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate, pH 7.4) in the presence of protease inhibitors (complete mini, Roche), and the supernatants collected after centrifugation at 15 000 g for 15 min were used. For cellular fractionation, tissues were homogenized in 0.25 M sucrose solution using five strokes of a Potter-type homogenizer, and differential centrifugation was performed. The precipitate after 600 g centrifugation for 10 min was regarded as the nuclear fraction; the precipitate after 8000 g centrifugation for 10 min was regarded as the mitochondrial fraction; the precipitate after 105 000 g for 60 min was regarded as the microsomal fraction; and the remaining supernatant was regarded as the cytosol. The protein concentration was determined with BCA protein reagents (Pierce, Rockford, IL, USA). Biochemical analyses were performed to ascertain the purity of each fraction. High amount of DNA content was considered as an indicator for the nuclear fraction. 29 Succinate dehydrogenase activity as an indicator for the mitochondrial fraction was determined by estimating the reduction of 2-(p-iodophenyl)-(p-nitrophenyl)-5-phenyl tetrazolium chloride. 30 NADPH-cytochrome c reductase activity as an indicator of the microsomal fraction was determined by measuring the reduction of cytochrome c at 550 nm. The reaction was conducted at 301C in a high ionic strength buffer as described. 31, 32 Lactate dehydrogenase (LDH) activity as an indicator of cytosolic fraction was determined by estimating the consumption of b-nicotinamide adenine dinucleotide (NADH) and the progression was observed at 340 nm. 33 Immunoprecipitation was performed as described 17 using 10 ml of Yat315 monoclonal antibody added to 400 mg of lysate in a 100-ml volume. IgG 1 immunoglobulin (Dako, clone DAK-GO1) was used as a negative control. The Sepharose beads were separated by centrifugation, and boiled with 50 ml of sample buffer containing 2-mercaptoethanol for 3 min. In all, 20 ml of the supernatant was electrophoresed in each lane for sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Western blotting was carried out as previously described. 34 NIH image freeware (ver. 1.62, http:// rsb.info.nih.gov/nih-image/) was used for the densitometric analyses.
Immunohistochemical Analysis
Tissues were fixed with 10% neutral formalin overnight, embedded in paraffin, cut at 3-mm thickness, and used for hematoxylin and eosin staining or immunohistochmistry. The avidin-biotin complex method with peroxidase was used for immunohistochemistry as described. 10 Antigen retrieval with a standard microwave irradiation method in 10 mM citrate buffer, pH 7.4, was used. For electronmicroscopic analyses, a pre-embedding method was used. Briefly, paraffin-embedded specimens were cut at 8-mm thickness, and immunohistochemistry was perfomed as described above.
3,3
0 -Diaminobenzidine solution (Dako Liquid DAB, K3466) was used for color development. Thereafter, the specimens were immediately postfixed with 2% glutaraldehyde in 50 mM phosphate-buffered saline, pH 7.4, for 45 min, dehydrated in a graded ethanol series, and embedded in Epon 812. Sections were cut with a diamond knife on a Sorvall MT-5000 ultramicrotome, mounted on copper grids coated with polyvinylformal, left unstained or stained with uranyl acetate, and observed with a Hitachi HU-12A electronmicroscope.
Northern Blot Analysis
Total RNA was isolated by means of a modified acid guanidinium phenol chloroform method (Isogen, Nippon Gene, Tokyo). Poly(A)-rich RNA was isolated using oligo(dT)-latex beads (Nippon Roche, Tokyo). For Northern blot analysis, poly(A)-rich RNA samples (2 mg) were separated by electrophoresis on a 1% agarose gel containing formaldehyde and transferred onto a nylon membrane. DNA fragments of rat TBP-2 (GenBank XM 215640: 510-1494) were amplified by PCR (sense, 5 0 -CCTACAGGTGAGAACGAGATGGTG-3 0 ; antisense, 5 0 -GGCAGAAAGCGTTGAGTAGTAGTACAGAT-3 0 ) using rat kidney cDNA as a substrate, purified and used as a probe after labeling with [a-32 P]dCTP by the random priming method (Megaprime DNA labeling kit, Amersham Pharmacia Biotech). Hybridization was performed as previously described. 17 
Mutational Analysis
Genomic sequences of TBP-2 were amplified using seven different sets (forward, F; reverse, R) of primers:
0 (681 base pairs (bp); base numbers calculated from the first ATG codon);
(792 bp). These amplified sequences covered all the exon sequences and more than 80% of the intronic sequences (B95% of the total TBP-2 gene area). PCR was performed in a 12.5-ml reaction mixture. The mixture contained 1 Â PfuUltra high fidelity (HF) reaction buffer (Stratagene, La Jolla, CA, USA), dNTPs (0.3 mM each) (Takara, Shiga, Japan), primers (5 pmol per reaction mixture), template DNA (30 ng) and 0.63 unit of PfuUltra HF DNA Polymerase (Stratagene, La Jolla, CA, USA). Amplification was carried out for 35 cycles (30 s at 951C, 30 s at 581C and 75 s at 721C), followed by a final 10-min extension at 721C. A zero blunt TOPO cloning kit (Invitrogen, Carlsbad, CA, USA) was used according to the manufacturer's instructions. Sequencing was performed using chain terminating big dye (Applied Biosystems, Foster city, CA, USA) and the sequences were compared with the rat genome database (NCBI, http://www.ncbi.nlm.nih.gov/) to evaluate the mutations.
Methylation-Specific PCR
Genomic DNA was extracted as described, 35 and methylation-specific PCR was performed as described. 36 The primers used are summarized in Table 1 .
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Results
TBP-2 and Trx Protein Analysis
In this model, acute renal tubular necrosis is observed 3 h after an intraperitoneal administration of Fe-NTA (15 mg iron/kg). Necrosis is prominent at 24 h, but tubular regeneration supervenes at 48 h. After repeated administration of Fe-NTA for 3 weeks, little necrosis is observed but karyomegalic cells appear. 9 TBP-2 was most abundant in the untreated rat kidney among the tissues examined by Western blot analysis (Figure 1a) . However, the amount was significantly decreased to less than 10% of the original amount 12-48 h after Fe-NTA administration. After the repeated administration of Fe-NTA for 3 weeks, a significant decrease of the amount of TBP-2 was observed. Furthermore, 21 out of 22 RCCs (95.5%) showed an undetectable amount of TBP-2. One adenoma (data not shown) and 1 RCC showed decreased amounts of TBP-2 ( Figure 1b) . The pattern of Trx protein expression was different from that of TBP-2 in that Trx protein was increased at 48 h, and that RCCs showed different levels of Trx protein according to their malignant potential. Basically, high-grade carcinoma expressed higher amounts of Trx (Figure 1b) .
TBP-2 mRNA Analysis
Notably, TBP-2 message remained at an almost constant level after oxidative renal tubular injury by Fe-NTA, and increased at 48 h. RCCs showed significantly decreased levels of TBP-2 message (Figure 1c ).
Immunohistochemical Analysis
By immunohistochemical analyses, TBP-2 was detected in the cytoplasm and nuclei of the renal proximal tubular cells, but not in the glomeruli. The cytoplasm showed a distinct granular pattern (Figure 2a TBP
Subcellular Localization of TBP-2
This study was performed on the untreated control kidney. Fractionation was performed by differential centrifugation to nuclear, mitochondrial, micro somal and cytosolic fractions, followed by confirmation with biochemical markers: DNA content, 196, 5.8, 0.0 and 2.4 mg/mg protein, respectively; succinate dehydrogenase activity, 0.0, 800, 0.0 and 0.0 OD at 490 nm/min/mg protein, respectively; NADPH-cytochrome c reductase activity, 0.050, not applicable, 83.0 and 0.013 nmol/min/mg protein, respectively; LDH activity, 16, 5.0, 14 and 100 mU/mg protein, respectively. Western blot analysis revealed that major amounts of TBP-2 were present in the nuclei and mitochondria, a small amount in the cytosol, and almost none in the microsomal fraction (Figure 2c ). Immunohistochemistry at the electronmicroscopic level showed the presence of TBP-2 in the intermembrane space of mitochondria and nuclei (Figure 2b ). Immunoprecipitation analyses of the mitochondrial fraction revealed the association of TBP-2 with cytochrome c (Figure 2d ).
Mutational Analysis of TBP-2
Rat TBP-2 genome sequences were obtained from the NCBI rat genome database. This gene was located on chromosome 2, and spanned 3875 bp with eight exons. Positions À785 to À208 from the initiation ATG codon were categorized as a CpG island with a CpG island searcher program (http:// ccnt.hsc.usc.edu/cpgislands/) (Figure 3a ). We found a unique type of deletion polymorphism in this CpG island producing interstrain differences at a potential site for methylation (Figure 3b and c). The poly-A tract in the distal part of the 3 0 untranslated region (UTR) also showed some variation of the number of mononucleotide repeats in different strains of rats. In the Wistar and Fischer-344 strains, the number of repeats was 16, whereas it was 15 in the BrownNorway strain. Furthermore, the poly-A tract in the 3 0 UTR was a frequent site for insertion and deletion mutations in the RCCs. The incidence of mutations was much lower in the coding exons and introns, and the mutations were all apparently silent (Table 2) .
CpG Island Methylation in the RCCs
Methylation-specific PCR analysis revealed that all the tumors examined showed methylation at the examined position of CpG island in the promoter region of TBP-2 gene (Figure 3d ).
Association between TBP-2 and Cellular Proliferation
Immunohistochemical analyses by the use of serial paraffin-embedded sections as well as Western blot analyses showed that PCNA positivity and TBP-2 positivity were inversely associated (Figures 1 and  4a-d) . After quantitating the results, the amounts of TBP-2 protein were significantly and inversely associated with the fraction of PCNA-positive cells with a certain threshold (Figure 4e ). In the present study, TBP-2 protein was undetectable by Western blot analysis when the fraction of PCNApositive cells in the tissue was approximately more than 55%. Within the range of 3-55% of PCNApositive cell fraction, the correlation coefficient was r 2 ¼ 0.988 (Po0.01). TBP-2 loss in oxystress-induced cancer KK Dutta et al
Discussion
We found that the TBP-2 gene is one of the major target genes in Fe-NTA-induced renal carcinogenesis. The mode of inactivation was transcriptional silencing via CpG island methylation, as previously observed in one-third of the cases of inactivation of p15 INK4B and p16 INK4A tumor suppressor genes in this model. 15 Furthermore, loss of TBP-2 in human T-cell leukemia virus I-transformed cell lines was associated with aberrant methylation of CpG island region (Ahsan KM, Masutani H and Yodoi J, unpublished data). This suggests the presence of certain common mechanisms facilitating the methylation of CpG island regions during oxidative stressinduced carcinogenesis that should be further explored.
We also observed interstrain polymorphisms and several kinds of mutations (Figure 3b , c and Table 1 ). All the mutations were apparently silent. However, in this rather nonselective genomic environment we may be able to evaluate the unbiased spectrum of ROS-induced mutagenesis. We found a high incidence of single nucleotide insertions or deletions in the poly-A tract of the distal part of 3 0 UTR. The C:G to T:A transition and G:C to T:A transversion mutations observed can be explained by the ROS-induced DNA base modifications. 3 Furthermore, we found that a decrease in TBP-2 was associated with non-neoplastic cellular proliferation in vivo, namely, the regeneration of renal proximal tubules (Figure 1b) . In this situation, however, ample amounts of message were observed (Figure 1c) , suggesting that certain post-transcriptional mechanisms play a role in shortening the halflife of this protein. One of the plausible explanations is that certain organelles work as a temporary reservoir for TBP-2. This will be discussed later in detail. We then studied the relationship between cellular proliferation and the presence of TBP-2 protein, and found that a decrease in TBP-2 was closely associated with the presence of PCNA (Figures 1b and 4e) . This was further confirmed by a morphological study revealing that TBP-2-positive cells were negative for PCNA and vice versa (Figure 4a-d) .
To elucidate the biological significance of the above observations, we examined the precise intracellular localization of TBP-2 in the rat kidney. The ubiquity of TBP-2 mRNA has been reported. However, we found an organ-specific difference in the amounts of TBP-2 protein (Figure 1a) . We believe that this is due to the fact that most of the previous studies assessed only TBP-2 mRNA, not protein. Studies showed increased levels of TBP-2 mRNA after oxidative stress 37 or glucose loading, 38 and a decrease in the mRNA level in several human [39] [40] [41] and animal tumors. 42 Re-evaluation of these experiments may be necessary because of the inconsistency between the mRNA and protein levels of TBP-2.
Our fractionation study revealed that TBP-2 was present mainly in the nuclear and mitochondrial fractions in the renal proximal tubules (Figure 2c) , which was consistent with the observation with immunostaining (Figure 2a) . Immunohistochemical analysis at the electronmicoscopic level clearly showed that TBP-2 was present in the intermembrane space of mitochondria (Figure 2b ) and in the nucleus. Cytochrome c is a soluble protein that associates through electrostatic interactions with the outer surface of the mitochondrial inner membrane and is involved in complexes III and IV in the oxidative phophorylation, and its release to the cytoplasm is one of the signals for the start of apoptosis. 43 In our immunoprecipitation study, we unexpectedly found that TBP-2 was associated with cytochrome c (Figure 2d ). Although the fraction of cytochrome c bound to TBP-2 appears small, this confirms the presence of TBP-2 in the intermembrane space of the mitochondria.
Protein interaction of TBP-2 in mitochondria merits immediate attention. It is well known that renal proximal tubular cells are metabolically active and are rich in mitochondria. 44 The precise role of Table 2 .
Sample numbers shown at the bottom of Figure 3d correspond with those of Figure 1 and Table 2 . M, methylated; U, unmethylated; C, untreated control kidney; G2, grade-2; G3, grade-3; L, lung metastasis; P, peritoneal invasion.
TBP-2 loss in oxystress-induced cancer KK Dutta et al 23 Recently, studies of a TBP-2-null mutant mouse 25 provided evidence that loss of TBP-2 results in enhanced sulfhydryl reduction and dysregulated carbohydrate and lipid metabolism, namely hyperinsulinemia, hypoglycemia, hypertriglyceridemia and increased levels of ketone bodies, at least in the liver and pancreatic b-cells. 47 On the other hand, it was shown that hyperglycemia inhibits the ROS-scavenging function of Trx through p38 MAPK-induction of TBP-2. 48 In the present study of renal carcinogenesis, loss of TBP-2 protein was induced only in a certain fraction of the renal tubular cells after Fe-NTA treatment and in the cancer cells (Figure 2e and f) . Loss of TBP-2 appears advantageous in cancer cells because it results in facilitation of the glycolytic pathway 47 in addition to the promotion of cellular proliferation since hypoxia is often associated with tumor growth. In a yeast two-hybrid screening using TBP-2 as bait, several clones encoding Trx2 were identified, demonstrating the interaction of TBP-2 with Trx2 in vitro (Wang D, Masutani H and Yodoi J, unpublished data). Studies are in progress to clarify the association among TBP-2, Trx2 and cytochrome c.
Third, mitochondria may work as a temporary reservoir for TBP-2. The nucleus appears to be the final destination of this protein. We found that TBP-2 ectopically expressed in the breast cancer cell line MCF-7 was localized predominantly in the nucleus exhibiting growth suppressive activity. 49 It was also reported that TBP-2 interacts with promyelocytic leukemia zinc-finger, Fanconi anemia zinc-finger and histone deacetylace 1, which are known to be transcriptional corepressors. 41 As a nuclear transport system, we recently identified importin a 1 (Rch1) as a protein interacting with TBP-2. The expression of short interfering RNA of importin a 1 suppressed suberoylanilide hydroxamic acid-induced nuclear accumulation of TBP-2.
49,50 Renal function is essential for the survival of the individual. A regulatory mechanism to maintain the renal tubular function by inhibiting mitosis may be necessary when a low level of damage occurs in the mitochondria of renal proximal tubules. In the Fe-NTA model, we previously reported that the mitochondria are major target organelles in the acute renal tubular injury by Fe-NTA. 51 It is possible that mild damage to mitochondria induces a release of TBP-2 to nuclei, leading to inhibition of mitosis. Severe damage or loss of TBP-2 loss in oxystress-induced cancer KK Dutta et al mitochondria may lead to loss of TBP-2 protein, resulting in a signal for mitosis. Renal proximal tubule is a site that merits further investigation of TBP-2 function in vivo.
In conclusion, TBP-2 protein is abundant in the mitochondria of the rat renal proximal tubular cells, where vitamin D is converted to an active form, and in the nuclei of these cells. TBP-2 expression is transcriptionally silenced in Fe-NTA-induced RCCs of rats by aberrant promoter methylation. Loss of TBP-2 is intimately associated with renal tubular proliferation in vivo irrespective of the molecular mechanisms involved and whether such proliferation is neoplastic or non-neoplastic.
